Drug Database
Back to search

Belgium· BE-AMP-SAM277076-00

Visipaque 320 mg I/ml

A iodixanol product containing iodixanol, registered in Belgium by GE Healthcare. The same ATC class is registered in 16 of our 19 countries.

ATC V08AB09

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedVisipaque 320 mg I/mlATCV08AB09REGISTER NO.BE-AMP-SAM277076-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about iodixanolAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Iodixanol is registered in 16 of 19 countries.

Countries holding a registration under ATC V08AB09 (iodixanol), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 9 of them publish a price we can compare per daily dose
Search iodixanol products by name

Iodixanol · ATC V08AB09

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Iodixanol
Manufacturer
GE Healthcare
Country
Belgium (BE)
ATC code
V08AB09
ATC class
Iodixanol
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    0787135
  • be_apb
    2430759

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

172 interactions on record for iodixanol.

Graded by severity as the source publishes them — 87 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check iodixanol against other medicinesHow interaction checks work

Iodixanol · interactions on record

172 records

  • 87 severe
  • 50 moderate
  • 35 info

Most severe, free to view

  • NeomycinA07AA01severe
  • StreptomycinA07AA04severe
  • Polymyxin BA07AA05severe
  • Amphotericin BA07AA07severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Iodixanol in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All iodixanol products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Visipaque
  • Bulgaria · Визипак
  • Cyprus · Visipaque
  • Czechia · Visipaque
  • Germany · Visipaque
  • Denmark · Visipaque
  • Estonia · Visipaque
  • Spain · Visipaque
  • Finland · Visipaque
  • France · Visipaque
  • United Kingdom (Northern Ireland) · Visipaque
  • Greece · Visipaque
  • Croatia · Visipaque
  • Hungary · Visipaque
  • Ireland · Visipaque Glass Container, Visipaque Polypropylene Container
  • Iceland · Visipaque
  • Italy · Visipaque
  • Lithuania · Visipaque
  • Luxembourg · Visipaque
  • Latvia · Visipaque
  • Malta · Visipaque
  • Netherlands · Visipaque
  • Norway · Visipaque
  • Poland · Visipaque
  • Portugal · Visipaque
  • Romania · Visipaque
  • Sweden · Visipaque
  • Slovenia · Visipaque
  • Slovakia · Visipaque

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c4f015f4-9254-465b-928b-01e53cfbb1d7
GET /v1/drugs/c4f015f4-9254-465b-928b-01e53cfbb1d7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Visipaque 320 mg I/ml",
  "name_fr": "Visipaque 320 mg I/ml",
  "name_nl": "Visipaque 320 mg I/ml",
  "amp_code": "SAM277076-00",
  "strengths": [
    "652.0000",
    "652.0000",
    "0.1000",
    "1.1100"
  ],
  "pack_count": 3,
  "substances": [
    "Iodixanol",
    "Calcium Disodium Edetate",
    "Sodium Chloride"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Iodixanol",
  "authorisation_numbers": [
    "BE277076"
  ]
}
API referenceMCP serverPlans

See everything about iodixanol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console